Table 3.
Metabolic syndrome parameters
| |
NGLCD |
LFD |
||||
|---|---|---|---|---|---|---|
| Baseline | 12 months | Mean change | Baseline | 12 months | Mean change | |
| WC (cm) |
92.7 ± 13.6 |
89.5 ± 11.9 |
−3.3 ± 3.6 [−4.3, -2.3] |
92.4 ± 11.7 |
89 ± 10.6 |
−3.4 ± 3.1 [−6.7, -0.96] |
| BMI (kg/m2) |
29.4 ± 3.5 |
28.9 ± 3.6 |
−1.4 ± 1.1 [−1.7, -1.1] |
29.4 ± 3.4 |
28.3 ± 3.4 |
−1.1 ± 0.9 [−1.3, -0.8] |
| Weight (kg) |
84.07 ± 13.2 |
80.09 ± 13.8 |
−3.9 ± 3.3 [−4.8, -3.1] |
83 ± 11.1 |
79.8 ± 11.5 |
−3.1 ± 2.6 [−3.8, -2.3] |
| Triglycerides (mg/dl) |
157.4 ± 50.8 |
128.5 ± 31 |
−28.9 ± 5.09 [−39.1, -18.8] |
164.6 ± 47.8 |
134.1 ± 32.3 |
−30.4 ± 38.7 [−41.2, -19.7] |
| HDL-cholesterol (mg/dl) |
42.7 ± 11.3 |
46 ± 10.2 |
3.3 ± 3.8 [4.3-2.3] |
42.3 ± 10.3 |
46.7 ± 8.9 |
4.4 ± 4.03 [3.3, 5.5] |
| FPG (mg/dl) |
104.1 ± 27.9 |
96.9 ± 19.7 |
−7.2 ± 11.2 [−10.2, -4.2] |
103.7 ± 29.2 |
96.5 ± 19.1 |
−7.2 ± 13.1 [−10.8, -3.5] |
| Cholesterol (mg/dl) |
212.4 ± 40.4 |
190.2 ±20.2 |
−22.1 ± 28.6 [−29.5, -14.7] |
209.1 ± 37 |
185 ± 16 |
−24.1 ± 27.5 [−31.8, -16.4] |
| SBP (mmHg) |
130.8 ± 11.2 |
125.9 ± 12.4 |
−4.8 ± 8.7 [−6.9,-2.7] |
143.7 ± 12.2 |
129.4 ± 11.2 |
−4.9 ± 6.1 [−6.5, -3.3] |
| DBP (mmHg) | 78.8 ±8.04 | 76.1 ± 8.6 | −2.6 ± 10.6 [−5.2,-0.06] | 84.8 ± 9.7 | 76.7 ± 10.3 | −3.8 ± 11.1 [−6.7, -0.96] |
Values are means ± SD; for mean change the results were expressed as means ± SD and 95% confidence intervals.
NGLCD normoglucidic low-calorie diet, LFD low-fat diet, WC waist circumference, BMI body mass index, HDL high density lipoproteins, FPG fasting plasma glucose, SBP systolic blood pressure, DBP diastolic blood pressure.
All p < 0.005 for within group change from baseline to 12 months; All p >0.05 for difference between groups at baseline and 12 months.